Clinical Trials Logo

Filter by:
NCT ID: NCT04752163 Completed - Clinical trials for Hematopoietic and Lymphoid Cell Neoplasm

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Start date: March 25, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the effect of DS-1594b with or without azacitidine, venetoclax, or mini-HCVD in treating patients with acute myeloid leukemia or acute lymphoblastic leukemia that has come back (recurrent) or not responded to treatment (refractory). Chemotherapy drugs, such as azacitidine, venetoclax, and mini-HCVD, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. DS-1594b may inhibit specific protein bindings that cause blood cancer. Giving DS-1594b, azacitidine, and venetoclax, or mini-HCVD may work better in treating patients with acute myeloid leukemia or acute lymphoblastic leukemia.

NCT ID: NCT04752033 Completed - Pain, Postoperative Clinical Trials

Intrathecal Opioids for Colorectal Resection

Start date: March 10, 2021
Phase: Phase 4
Study type: Interventional

This research study is being done to determine the optimal dose of spinal morphine and hydromorphone in patients undergoing minimally-invasive (i.e., surgery performed through small entry sites and using cameras) colorectal surgery.

NCT ID: NCT04752020 Completed - Clinical trials for Fuchs' Endothelial Dystrophy

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

Start date: March 28, 2021
Phase: Early Phase 1
Study type: Interventional

This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative central endothelial cell counts. The anticipated enrollment is 25 patients.

NCT ID: NCT04751656 Completed - Clinical trials for Overweight and Obesity

Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment (STEADY)

STEADY
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

The goal of this pilot trial is to pilot test an intervention to help prevent weight gain or produce weight loss among adults with obesity. Participants are asked to self-weigh on a smart scale for one year. Feasibility and acceptability outcomes are examined.

NCT ID: NCT04751461 Completed - Smoking Clinical Trials

CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems

Start date: February 23, 2021
Phase: N/A
Study type: Interventional

This is an open-label, randomized, 5-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.

NCT ID: NCT04751240 Completed - Body Composition Clinical Trials

Effect of Interval and Resistance Exercise on Physiological and Psychological Parameters.

Start date: January 20, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the physiological and psychological effects of a sprint interval and resistance training intervention on females.

NCT ID: NCT04751045 Completed - Clinical trials for Chronic Liver Disease

Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies

Start date: October 25, 2020
Phase: N/A
Study type: Interventional

Histopathological examination of liver tissue is used to determine the etiology and extent of liver disease. In order for a clinician to make a better-informed decision regarding a patient with liver disease, the liver biopsy specimen has to be adequate and of high quality for pathological interpretation. It is generally agreed that an adequate liver biopsy has to have ≥6-12 intact portal tracts for pathological review and interpretation.(1) Historically, three approaches have been used to obtain a liver biopsy: percutaneous, transjugular (TJ-LB) and laparoscopic approach (LA-LB)- with percutaneous liver biopsy (P-LB) being the most commonly employed. Endoscopic ultrasound-guided liver biopsy (EUS-LB), a newer approach, is now being performed by select skilled endoscopists across the country. EUS-LB is advantageous over existing techniques because it enables visualization and avoidance of vessels that are 1mm in diameter, provides access to both lobes of the liver and theoretically is less painful due to avoiding somatic pain fibers. Further, in patients that are already undergoing esophagogastroduodenoscopy, EUS-LB can be performed simultaneously and spare the patient an additional procedure. Because of the plausibility of reduced pain, number of procedures and possibly complications, EUS-LB may be cost-effective over existing methods. There is limited data evaluating the safety and efficacy of EUS-LB versus percutaneous liver biopsy. The investigators hope to provide answers in a prospective study comparing between patients, who are already undergoing liver biopsy, randomly assigned to either EUS-LB or P-LB. The investigators will compare outcomes such as pain, bleeding, hospitalization, and tissue diagnosis between the two groups. This will allow us to add to the existing data for the use of EUS-LB. If patients are found to have less adverse events and better outcomes using EUS-LB versus percutaneous-LB this may become the preferred method of diagnosis in this patient population.

NCT ID: NCT04750902 Completed - Dental Caries Clinical Trials

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

Start date: January 21, 2021
Phase: Phase 2
Study type: Interventional

The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.

NCT ID: NCT04750824 Completed - Clinical trials for Non-squamous, Non-Small Cell Lung Cancer

Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.

Start date: October 15, 2020
Phase:
Study type: Observational

Characteristics of patients with Neuregulin-1 (NRG1) gene fusion-positive solid tumors treated with afatinib, and characteristics of those treated with another systemic therapy.

NCT ID: NCT04750785 Completed - Choroideremia Clinical Trials

A Study to Assess Choroideremia (CHM) Health Outcomes

Start date: December 15, 2020
Phase:
Study type: Observational

The primary objectives of this study are to describe disease progression and severity by age in participants with CHM, to assess health-related quality-of-life, resource utilization and work productivity, and to assess quality-of-life, work productivity, and impact on daily activities in caregivers of participants with CHM at different stages of disease progression.